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MicroRNA miR-155 Affects Antiviral Effector and Effector Memory
CD8 T Cell Differentiation
Ching-Yi Tsai, S. Rameeza Allie, Weijun Zhang, Edward J. Usherwood
Microbiology and Immunology Department, Geisel School of Medicine at Dartmouth College, Lebanon, New Hampshire, USA
MicroRNAs are key regulators of the immune response, but their role in CD8 T cell differentiation in vivo is not known. We
show that miR-155 is important in both effector and memory antiviral CD8 T cell responses. Without miR-155, there was a
weaker effector response and a skewing toward memory precursor cells. At the memory stage, miR-155-deficient CD8 T cells
preferentially differentiated into central memory cells and were capable of mounting a potent secondary response.
For intracellular pathogens, a crucial part of long-term immu-nity is the generation of memory CD8 T cells. Naïve T cells can
be directed toward at least two different fate-determining path-
ways after antigen (Ag) exposure. One pathway, driven by IL-12
and IL-2 signaling, upregulates T box expressed in T cell (T-bet)
expression, resulting in terminal differentiation of short-lived ef-
fector cells (SLECs). Alternatively, a pathway driven by lower lev-
els of IL-12 but stimulated by IL-21 or IL-10 leads to production of
memory precursor effector cells (MPECs), which display less ef-
fector activity than SLECs (1). The ultimate repository for long-
term memory is the central memory T cell (Tcm), and understand-
ing how T cells can be directed toward this fate has profound
implications for vaccine design. Given the distinct transcriptional
profiles of effector and memory cells (2), it is an open question if
there are master regulators of gene expression in these cells.
MicroRNAs (miRNAs) are important posttranscriptional regula-
tors in many developmental processes. Several miRNAs have been
shown to be critical in many stages of hematopoietic development
(3). While miRNAs have been shown to influence CD4 T cell and
regulatory T cell differentiation, it is currently unclear which
miRNAs influence CD8 T cell differentiation.
Studies using CD8 T cells lacking dicer, an enzyme essential for
the processing of all miRNAs, showed deficits in CD8 T cell accu-
mulation and survival (4). Other studies profiled miRNA expres-
sion following CD8 T cell activation in vitro (5, 6). Upregulation of
miR-21 and miR-155 was observed, which was interesting due to
previous studies implicating roles for them in immune cell func-
tion (7, 8). In another study, CD8 T cells cultured in vitro to
resemble central memory cells downregulated miR-155 relative to
effector CD8 T cells (9). While these studies implied miR-155
involvement in CD8 T cell differentiation and memory develop-
ment, it is still unclear which processes are affected by miR-155
during T cell differentiation in vivo. Here we report that miR-155
plays a critical role in the generation of memory CD8 T cells dur-
ing virus infection in vivo.
Discussion. To determine the kinetics of miR-155 expression
after CD8 T cell activation, we simulated OT-I cells with antigen in
vitro and measured miR-155 expression by PCR. miR-155 expres-
sion peaked at 3 days poststimulation and then declined at all
subsequent time points (Fig. 1). The decline in miR-155 was much
more marked in cells cultured with IL-15 than in cultures supple-
mented with IL-2, resulting in significantly lower levels of miR-
155 at days 4, 5, and 6 after activation. Culture with IL-2 generates
effector/effector memory phenotype CD8 T cells, whereas IL-15
generates cells with central memory characteristics (10). These
data therefore implied that sustained miR-155 expression was as-
sociated with effector/effector memory cells, whereas central
memory cells were associated with lower miR-155 expression.
Next we assessed the role of miR-155 in the antiviral CD8 T cell
response in vivo. As miR-155 has been shown to affect the biology
of multiple hematopoietic cell types (11–13), we chose a system
where CD8 T cell-intrinsic effects could be measured. To measure
the relevance of miR-155 for viral control, we constructed mixed-
bone marrow chimeric mice such that miR-155 was absent from
the entire CD8 T cell compartment. Following infection with mu-
rid herpesvirus 68 (MHV-68), viral titers in the lung were deter-
mined by standard plaque assay (13) at day 14 postinfection. Viral
titers were significantly higher in chimeric mice lacking miR-155
in CD8 T cells than in mice with intact miR-155 in CD8 T cells
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FIG 1 miR-155 expression in CD8 T cells following activation. OT-I T cells
were cultured with SIINFEKL peptide (1 ng/ml) for 3 days and then cultured
with either IL-2 (10 U/ml) or IL-15 (10 ng/ml) for an additional 3 days. Total
RNA was extracted from cultures on days 2, 3, 4, 5, and 6. We then performed
microRNA-specific reverse transcription followed by quantitative PCR
(qPCR) for miR-155, using PCR for small nucleolar RNA 202 (snoRNA202) as
an internal standard. Graphs show means  standard deviations. ***, P 
0.01.
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(Fig. 2A). In order to study the effect of miR-155 deficiency on the
biology of the CD8 T cell compartment, without the potentially
confounding factor of differences in viral load, mixed-bone mar-
row chimeric mice were generated such that both wild-type (WT)
and miR-155/ CD8 T cells were present in the same infected
mouse (14). The proportions and surface phenotypes (CD127,
KLRG-1, CD122, and CD62L) were comparable between the miR-
155/ and WT CD8 T cells before infection in these mice (data
not shown). Upon infection with MHV-68, the epitope-specific
primary CD8 T cell response from each population was measured.
We observed an attenuated effector response from miR-155/
CD8 T cells at the acute phase (Fig. 2B, top). Phenotypic analysis
FIG 2 Effect of miR-155 on the primary antiviral CD8 T cell response to MHV-68. (A) Bone marrow from miR-155/ and CD8/ mice were mixed in a 1:1
ratio and then injected intravenously into lethally irradiated RAG/ mice (miR-155 group) to generate mice lacking miR-155 in all CD8 T cells. As a control,
wild-type bone marrow was mixed with CD8/ bone marrow (WT group), such that all CD8 T cells were wild type. After reconstitution of the immune system,
mice were infected with MHV-68 and the lung viral titer was measured on day 10 postinfection. (B to E) Mixed-bone marrow chimeric mice were generated by
injecting lethally irradiated B6 mice with a 1:1 ratio of miR-155 and WT bone marrow. Therefore, both miR-155/ and WT CD8 T cells were present in the same
mouse but expressed different congenic markers, allowing us to distinguish the two populations. Following immune reconstitution, mice were infected
intranasally with 400 PFU of MHV-68, and various organs were removed at 14 days postinfection. The antigen-specific CD8 T response was measured by ORF61
tetramer staining. MFI, mean fluorescence intensity. (B, top) Numbers of total ORF61 tetramer-positive CD8 T cells and percentages of ORF61-specific CD8 T
cells among total CD8 T cells. (Bottom) Percentages of KLRG1 cells and the fluorescence intensity of CD127 staining in the ORF61-specific CD8 T cell
population. (C) Representative flow cytometric plots for IL-21R and Bcl-2 staining gated on ORF61-specific CD8 T cell populations. Graphs show values
obtained, with each point representing a single mouse. KO, knockout. (D) Mean fluorescence intensity of T-bet and eomesodermin staining in the ORF61-
specific CD8 populations. (E) CD8 T cells were stained to measure the production of IFN-, IL-2, TNF-, and granzyme B after brief antigen simulation in vitro.
Plots were gated on IFN--producing CD8 T cell populations. Each point represents data from an individual mouse. Data are representative of three experiments.
The limit of detection was 10 PFU per lung (dotted line). *, P  0.05; **, P  0.01; ***, P  0.001.
miR-155 and CD8 T Cell Differentiation
February 2013 Volume 87 Number 4 jvi.asm.org 2349
showed markedly higher CD127 expression by miR-155/ cells
and lower KLRG1 expression (Fig. 2B, bottom), indicative of a
skewing toward MPECs. Similar data were obtained from the lung
and mediastinal lymph nodes. These changes were also observed
for the subdominant ORF6 epitope, showing that this was not an
epitope-dependent phenomenon (data not shown).
The miR-155 population also exhibited elevated expression of
the IL-2 receptor (IL-21R) and Bcl-2, markers indicative of mem-
ory cells (Fig. 2C). Levels of expression of transcription factors
associated with the activation of effector-associated genes, T-bet
and eomesodermin, were equivalent between WT and miR-
155/ cells (Fig. 2D). As expected, the frequency of CD8 T cells
producing gamma interferon (IFN-) was reduced in the absence
of miR-155 (Fig. 2E). No difference was detected in the propor-
tions of cells producing tumor necrosis factor alpha (TNF-) or
the levels of granzyme B produced (Fig. 2E). However, we detected
a significantly elevated production of IL-2 (Fig. 2E), consistent
with phenotypic skewing toward the MPEC phenotype.
As our data indicated preferential generation of an MPEC phe-
notype, we tested a later time postinfection (day 28), after the
resolution of the acute infection. The overall magnitude of the
memory response was decreased in the miR-155/ population
(Fig. 3A). Consistently with our previous research (15), the mem-
ory CD8 T cell response was dominated by effector memory (low-
expression CD62L [CD62Llo]) cells in the WT population. How-
ever, a significantly larger proportion of miR-155/ cells were
CD62Lhi, consistent between several different organs (Fig. 3A).
Analysis of effector functions revealed a decreased proportion of
IFN-, but TNF- and granzyme B production was unaffected
(Fig. 3B). However, miR-155/ cells produced markedly more
IL-2 than the equivalent WT cells (Fig. 3B). These phenotypic and
functional changes were also observed at day 60 postinfection but
with a larger difference between the experimental groups with
regard to CD62L expression (Fig. 4A and B). Collectively, these
data indicated a significantly larger proportion of central memory
cells within the miR-155/ CD8 T population. This was consis-
tent with our in vitro data, which associated lower miR-155 ex-
pression with central memory differentiation.
To test whether memory CD8 T cells remained functional in
the absence of miR-155, chimeric mice were challenged with a
recombinant vaccinia virus encoding the ORF61 epitope from
MHV-68, 60 days after MHV-68 infection. Both the WT and miR-
155/ populations expanded equivalently (Fig. 5), indicating
that the secondary proliferative capacity of central memory-
skewed miR-155/ memory CD8 T cells was intact.
Little is known about the role played by specific miRNAs in
CD8 T cell immunity to viruses in vivo, and this study highlights a
critical role for miR-155 in this process. These data indicate that
miR-155 plays an important role in the generation and/or main-
tenance of both effector and effector memory CD8 T cells during
virus infection. Our data show that the absence of miR-155 results
in a marked reduction in the effector response during the acute
stage of infection, but the remaining cells have a higher proportion
of MPECs. During the memory phase of the response, in the ab-
sence of miR-155, more cells expressed CD62L and IL-2, indica-
tive of a central memory phenotype. This was observed in several
FIG 3 Early skewing toward a central memory phenotype. Cells from the
organs indicated were harvested from MHV-68-infected mixed-bone marrow
chimeric mice at day 28 postinfection. Cells were stained with ORF61 tetramer
plus antibody to CD62L. (A) Percentages of ORF61-specific cells among the
CD8 T cell populations and percentages of CD62Lhi cells among the ORF61-
specific CD8 T cell population. (B) CD8 T cells were stained to measure the
production of IFN-, IL-2, TNF-, and granzyme B. Plots were gated on IFN-
-producing CD8 T cell populations. Each point represents data from an in-
dividual mouse. Data are representative of three experiments. *, P  0.05; **,
P  0.01. LN, mediastinal lymph node; SP, spleen; LG, lung.
FIG 4 Memory Ag-specific miR155/ CD8 T cells that are present at a low
frequency have a central memory phenotype. Mixed-bone marrow chimeric
mice were intranasally infected with 400 PFU of MHV-68. (A) Sixty days
postinfection, Ag-specific CD8 T cells were identified using ORF61 tetramer in
the organs shown, and the percentages of CD62Lhi were measured. (B) IFN-
or IL-2 production in the IFN- CD8 T cells was measured with intracellular
cytokine staining. Each point represents data from an individual mouse. Data
are representative of three experiments. *, P  0.05; **, P  0.01; ***, P 
0.001. SP, spleen; LG, lung; LV, liver; BM, bone marrow.
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organs, suggesting that this represents a systemic change in the
CD8 T cell phenotype rather than a redistribution of central or
effector memory cells between the WT and miR-155/ popula-
tions. Interestingly, memory cells expanded similarly upon sec-
ondary viral challenge, indicating that the defect observed during
the primary response was not manifest during the recall response.
As central memory CD8 T cells have been shown to confer supe-
rior immunity both in vivo and in adoptive-cell transfer studies,
suppressing miR-155 may prove a useful way to preferentially
generate these cells and lead to better immune therapies.
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FIG 5 The secondary proliferative response was intact in the absence of miR-
155. To measure the magnitude of the recall response, MHV-68-infected mice
at day 60 postinfection were challenged with 2  10e7 vaccinia virus encoding
ORF61 intraperitoneally and monitored at 6 days postchallenge. Ag-specific
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numbers shown indicate the average fold differences in numbers of ORF-61-
specific CD8 T cells for each group. Each dot represented an individual recip-
ient. Note the different scales in panels A and B, reflecting an increased pro-
portion of ORF61-specific cells after rechallenge. Representative plots from
two independent experiments using three to four mice per group are shown.
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